Enzi Wealth Abb Vie Inc. Transaction History

Enzi Wealth

$224 Million
Q2 2024

A detailed history of Enzi Wealth transactions in Abb Vie Inc. stock. As of the latest transaction made, Enzi Wealth holds 1,449 shares of ABBV stock, worth $281,511. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,449

Previous 1,363 6.31%

Holding current value

$281,511

Previous $248,000 -0.0%

% of portfolio

0.11%

Previous 0.11%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $13,311 - $15,545	86 Added 6.31%	1,449 $248,000
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $159 - $182	1 Added 0.07%	1,363 $248,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $137 - $154	1 Added 0.07%	1,362 $211,000
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $181,815 - $210,478	1,361 New	1,361 $202,000
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $433 - $499	3 Added 0.21%	1,461 $232,000
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $1,659 - $1,990	12 Added 0.83%	1,458 $0
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $194,067 - $222,582	1,446 New	1,446 $217,000

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enzi Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Enzi Wealth with notifications on news.

Account